Researchers have discovered how dormant pancreatic cancer cells manipulate their surroundings to evade CAR T-cell therapy, identifying a potential therapeutic target for overcoming treatment resistance.
Protein damage could provide a valuable readout for evaluating potential anti-ageing therapies, but reducing complex biological responses to a single score raises important questions about interpretation and validation.
The PsychAD Consortium is using human genetics, single-cell genomics and automated screening to pinpoint potential drug targets for Alzheimer’s disease and investigate their therapeutic potential.
Making better decisions in drug discovery is not down to implementing more tools. Here, Dr Harsh Shah reveals why teams must start by defining the scientific question.
A study led by the Josep Carreras Leukaemia Research Institute has uncovered how cancer cells manage formaldehyde toxicity without compromising their defences against ferroptosis.
A genetically attenuated strain of Salmonella Typhimurium carrying both a pro-apoptotic protein and immune-stimulating epitopes has demonstrated significant reductions in tumour growth and metastatic spread in preclinical models of aggressive breast cancer.
Bioengineers at UC San Diego have created RNA-based molecular switches that use small-molecule drugs to precisely regulate therapeutic protein production, offering a potential solution to one of gene therapy’s most persistent challenges.
A large-scale single-cell atlas of ductal carcinoma in situ has identified novel stromal structures and microenvironmental features that may help distinguish lesions at risk of progressing to invasive breast cancer.
Six scientists and industry experts discuss the challenges of automating drug discovery, from improving screening reliability and reproducibility to developing more autonomous laboratories.
Poor recovery, inconsistent growth and changes in morphology can affect organoid research. How much experimental variability starts with the culture itself?
How can multiomics help researchers identify more promising drug targets? Dr Shi-qi An explores how combining molecular data can reveal therapeutic vulnerabilities and mechanisms of drug resistance.